An angiogenic role for the alpha 5 beta 1 and alpha V beta 3 integrins during cer

α 5 β 1 和 α V β 3 整合素在 cer 过程中的血管生成作用

基本信息

  • 批准号:
    7652306
  • 负责人:
  • 金额:
    $ 37.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-15 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ischemic stroke is a major cause of morbidity and mortality in the western world. Despite intensive research in this field, current options for treatment are still limited. One approach to preventing stroke or promoting recovery after stroke is to encourage the growth of new blood vessels (angiogenesis), to restore vascular delivery to the ischemic area. Angiogenesis is regulated by growth factors, cytokines, and extracellular matrix (ECM) proteins like fibronectin. The hypothesis to be tested by this proposal is that cerebral ischemia induces brain endothelial cell expression of the a5¿1 and av¿3 integrins, and that fibronectin promotes cerebral angiogenesis, via these integrins. Studies outside the central nervous system (CNS) show that the a5¿1 and av¿3 integrins are strongly induced on sprouting blood vessels, and functional blockade of these integrins inhibits angiogenesis in animal models of tumor formation and diabetic neovascularization. Evidence from our laboratory suggests that these integrins may also promote angiogenesis in the CNS: (i) developmental angiogenesis is strongly associated with brain endothelial expression of the a5¿1 integrin, (ii) the a5¿1 integrin is also strongly induced on angiogenic endothelial cells during hypoxia in the adult CNS, (iii) following cerebral ischemia, ¿1 integrin mRNA levels are increased in the ischemic penumbra, where new vessel sprouting occurs, (iv) the av¿3 integrin is induced on angiogenic endothelial cells rapidly following cerebral ischemia, and (v) in vitro studies of brain endothelial cells demonstrate that the survival and mitogenic effects of fibronectin are mediated by both the a5¿1 and av¿3 integrins. The hypothesis will be tested using a combination of in vivo and in vitro approaches. Endothelial expression of the a5¿1 and av¿3 integrins will be examined in mouse models of focal cerebral ischemia, and cerebral hypoxia. The role of the av¿3 integrin in cerebral angiogenesis will be directly examined in both animal models using ¿3 integrin null mice. Potential roles for the a5¿1 and av¿3 integrins in regulating mouse brain endothelial cell behavior will be addressed by using endothelial cells deficient in these integrins. Finally, the time-course and cellular source of the pro-angiogenic factor, TGF-¿1 will be defined in these systems. This study has three Specific Aims: 1) demonstrate induction of the a5¿1 and av¿3 integrins on brain endothelial cells following ischemia or hypoxia in cerebral tissue; 2) demonstrate an instructive role for the a5¿1 and av¿3 integrins in promoting brain endothelial cell survival, proliferation, migration, and capillary formation; and 3) define the time-course and cellular origin of the pro-angiogenic factor, TGF- ¿1 following cerebral ischemia and cerebral hypoxia. These studies will directly test the idea that the a5¿1 and av¿3 integrins play an important role in promoting cerebral angiogenesis in response to ischemia. Based on this work, manipulation of the expression level or signaling of these integrins are likely to provide a promising approach to enhance cerebral angiogenesis, either before or immediately after ischemic stroke. PUBLIC HEALTH RELEVANCE: The overall aim of this Project is to examine the notion that cerebral ischemia induces endothelial cell expression of the a5¿1 and av¿3 integrins, and that fibronectin promotes new blood vessel formation in the brain via these integrins. Based on this work, manipulation of the expression levels or signaling pathways of these integrins may provide a promising therapeutic approach to enhance cerebral blood vessel growth, either before or immediately after ischemic stroke. If successful, this work could have major impact on the incidence and mortality of ischemic stroke.
描述(由申请人提供):缺血性中风是西方世界发病率和死亡率的主要原因。尽管在这一领域进行了深入的研究,但目前的治疗选择仍然有限。预防中风或促进中风后恢复的一种方法是促进新血管的生长(血管生成),以恢复向缺血区域的血管输送。血管生成受生长因子、细胞因子和细胞外基质(ECM)蛋白如纤维连接蛋白的调控。该提议所验证的假设是,脑缺血诱导脑内皮细胞表达a5¿1和a5¿3整合素,而纤维连接蛋白通过这些整合素促进脑血管生成。中枢神经系统(CNS)以外的研究表明,a5¿1和a5¿3整合素对新生血管有强烈的诱导作用,在肿瘤形成和糖尿病新生血管的动物模型中,这些整合素的功能阻断会抑制血管生成。我们实验室的证据表明,这些整合素也可能促进中枢神经系统的血管生成:(i)发育性血管生成与脑内皮细胞中a5¿1整合素的表达密切相关,(ii)成人中枢神经系统缺氧时,a5¿1整合素也在血管生成内皮细胞上被强烈诱导,(iii)脑缺血后,a5¿1整合素mRNA水平在缺血半暗区(新血管萌发的地方)升高,(iv)脑缺血后,a5¿1整合素在血管生成内皮细胞上被迅速诱导。(v)脑内皮细胞的体外研究表明,a5¿1和a5¿3整合素介导了纤连蛋白的存活和有丝分裂作用。该假设将采用体内和体外方法相结合的方法进行检验。a5¿1和a5¿3整合素的内皮表达将在小鼠局灶性脑缺血和脑缺氧模型中进行检测。在这两种动物模型中,我们将使用缺乏整合素的小鼠直接研究av - 3整合素在脑血管生成中的作用。a5¿1和a5¿3整合素在调节小鼠脑内皮细胞行为中的潜在作用将通过使用缺乏这些整合素的内皮细胞来解决。最后,确定促血管生成因子TGF-¿1在这些系统中的时间过程和细胞来源。本研究有三个具体目的:1)证明脑缺血或缺氧后a5¿1和a5¿3整合素对脑内皮细胞的诱导作用;2) a5¿1和a5¿3整合素在促进脑内皮细胞存活、增殖、迁移和毛细血管形成中的指导作用;3)明确脑缺血和脑缺氧后促血管生成因子TGF-¿1的时间过程和细胞来源。这些研究将直接验证a5¿1和a5¿3整合素在缺血反应中促进脑血管生成中起重要作用的观点。基于这项工作,操纵这些整合素的表达水平或信号传导可能为在缺血性中风之前或之后立即增强脑血管生成提供了一种有希望的方法。公共卫生相关性:本项目的总体目的是研究脑缺血诱导内皮细胞表达a5¿1和a5¿3整合素的概念,以及纤维连接蛋白通过这些整合素促进大脑中新血管的形成。基于这项工作,操纵这些整合素的表达水平或信号通路可能提供一种有希望的治疗方法,可以在缺血性中风之前或之后立即促进脑血管生长。如果成功,这项工作将对缺血性脑卒中的发病率和死亡率产生重大影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

D. Richard MILNER其他文献

D. Richard MILNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('D. Richard MILNER', 18)}}的其他基金

The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID
小胶质细胞在防止血脑屏障完整性和 VCID 缺氧破坏中的保护作用
  • 批准号:
    10097078
  • 财政年份:
    2021
  • 资助金额:
    $ 37.79万
  • 项目类别:
A vasculo-protective role for beta4 integrin in neuroinflammation
β4 整合素在神经炎症中的血管保护作用
  • 批准号:
    10348655
  • 财政年份:
    2018
  • 资助金额:
    $ 37.79万
  • 项目类别:
A vasculo-protective role for beta4 integrin in neuroinflammation
β4 整合素在神经炎症中的血管保护作用
  • 批准号:
    10093147
  • 财政年份:
    2018
  • 资助金额:
    $ 37.79万
  • 项目类别:
An angiogenic role for the alpha 5 beta 1 and alpha V beta 3 integrins during cer
α 5 β 1 和 α V β 3 整合素在 cer 过程中的血管生成作用
  • 批准号:
    7872776
  • 财政年份:
    2008
  • 资助金额:
    $ 37.79万
  • 项目类别:
An angiogenic role for the alpha 5 beta 1 and alpha V beta 3 integrins during cer
α 5 β 1 和 α V β 3 整合素在 cer 过程中的血管生成作用
  • 批准号:
    7526437
  • 财政年份:
    2008
  • 资助金额:
    $ 37.79万
  • 项目类别:
An angiogenic role for the alpha 5 beta 1 and alpha V beta 3 integrins during cer
α 5 β 1 和 α V β 3 整合素在 cer 过程中的血管生成作用
  • 批准号:
    8089233
  • 财政年份:
    2008
  • 资助金额:
    $ 37.79万
  • 项目类别:
An angiogenic role for the alpha 5 beta 1 and alpha V beta 3 integrins during cer
α 5 β 1 和 α V β 3 整合素在 cer 过程中的血管生成作用
  • 批准号:
    8286351
  • 财政年份:
    2008
  • 资助金额:
    $ 37.79万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了